Request for Covid-19 Impact Assessment of this Report
The United States Prescription Pain Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Pain Medications market, reaching US$ million by the year 2028. As for the Europe Prescription Pain Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Prescription Pain Medications players cover Pfizer, GSK, Grunenthal, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Pain Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
J&J
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Pain Medications Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Prescription Pain Medications by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Prescription Pain Medications by Country/Region, 2017, 2022 & 2028
2.2 Prescription Pain Medications Segment by Type
2.2.1 Prescription NSAIDs
2.2.2 Opioids
2.2.3 Anti-epileptic Medicines
2.2.4 Antidepressants
2.2.5 Others
2.3 Prescription Pain Medications Sales by Type
2.3.1 Global Prescription Pain Medications Sales Market Share by Type (2017-2022)
2.3.2 Global Prescription Pain Medications Revenue and Market Share by Type (2017-2022)
2.3.3 Global Prescription Pain Medications Sale Price by Type (2017-2022)
2.4 Prescription Pain Medications Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.4.4 Others
2.5 Prescription Pain Medications Sales by Application
2.5.1 Global Prescription Pain Medications Sale Market Share by Application (2017-2022)
2.5.2 Global Prescription Pain Medications Revenue and Market Share by Application (2017-2022)
2.5.3 Global Prescription Pain Medications Sale Price by Application (2017-2022)
3 Global Prescription Pain Medications by Company
3.1 Global Prescription Pain Medications Breakdown Data by Company
3.1.1 Global Prescription Pain Medications Annual Sales by Company (2020-2022)
3.1.2 Global Prescription Pain Medications Sales Market Share by Company (2020-2022)
3.2 Global Prescription Pain Medications Annual Revenue by Company (2020-2022)
3.2.1 Global Prescription Pain Medications Revenue by Company (2020-2022)
3.2.2 Global Prescription Pain Medications Revenue Market Share by Company (2020-2022)
3.3 Global Prescription Pain Medications Sale Price by Company
3.4 Key Manufacturers Prescription Pain Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Pain Medications Product Location Distribution
3.4.2 Players Prescription Pain Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prescription Pain Medications by Geographic Region
4.1 World Historic Prescription Pain Medications Market Size by Geographic Region (2017-2022)
4.1.1 Global Prescription Pain Medications Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Prescription Pain Medications Annual Revenue by Geographic Region
4.2 World Historic Prescription Pain Medications Market Size by Country/Region (2017-2022)
4.2.1 Global Prescription Pain Medications Annual Sales by Country/Region (2017-2022)
4.2.2 Global Prescription Pain Medications Annual Revenue by Country/Region
4.3 Americas Prescription Pain Medications Sales Growth
4.4 APAC Prescription Pain Medications Sales Growth
4.5 Europe Prescription Pain Medications Sales Growth
4.6 Middle East & Africa Prescription Pain Medications Sales Growth
5 Americas
5.1 Americas Prescription Pain Medications Sales by Country
5.1.1 Americas Prescription Pain Medications Sales by Country (2017-2022)
5.1.2 Americas Prescription Pain Medications Revenue by Country (2017-2022)
5.2 Americas Prescription Pain Medications Sales by Type
5.3 Americas Prescription Pain Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Pain Medications Sales by Region
6.1.1 APAC Prescription Pain Medications Sales by Region (2017-2022)
6.1.2 APAC Prescription Pain Medications Revenue by Region (2017-2022)
6.2 APAC Prescription Pain Medications Sales by Type
6.3 APAC Prescription Pain Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prescription Pain Medications by Country
7.1.1 Europe Prescription Pain Medications Sales by Country (2017-2022)
7.1.2 Europe Prescription Pain Medications Revenue by Country (2017-2022)
7.2 Europe Prescription Pain Medications Sales by Type
7.3 Europe Prescription Pain Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prescription Pain Medications by Country
8.1.1 Middle East & Africa Prescription Pain Medications Sales by Country (2017-2022)
8.1.2 Middle East & Africa Prescription Pain Medications Revenue by Country (2017-2022)
8.2 Middle East & Africa Prescription Pain Medications Sales by Type
8.3 Middle East & Africa Prescription Pain Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Pain Medications
10.3 Manufacturing Process Analysis of Prescription Pain Medications
10.4 Industry Chain Structure of Prescription Pain Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Pain Medications Distributors
11.3 Prescription Pain Medications Customer
12 World Forecast Review for Prescription Pain Medications by Geographic Region
12.1 Global Prescription Pain Medications Market Size Forecast by Region
12.1.1 Global Prescription Pain Medications Forecast by Region (2023-2028)
12.1.2 Global Prescription Pain Medications Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prescription Pain Medications Forecast by Type
12.7 Global Prescription Pain Medications Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Prescription Pain Medications Product Offered
13.1.3 Pfizer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Prescription Pain Medications Product Offered
13.2.3 GSK Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Grunenthal
13.3.1 Grunenthal Company Information
13.3.2 Grunenthal Prescription Pain Medications Product Offered
13.3.3 Grunenthal Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grunenthal Main Business Overview
13.3.5 Grunenthal Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Prescription Pain Medications Product Offered
13.4.3 Bayer Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Prescription Pain Medications Product Offered
13.5.3 Sanofi Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Prescription Pain Medications Product Offered
13.6.3 Eli Lilly Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Prescription Pain Medications Product Offered
13.7.3 AstraZeneca Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo Prescription Pain Medications Product Offered
13.8.3 Endo Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Prescription Pain Medications Product Offered
13.9.3 Merck Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Depomed
13.10.1 Depomed Company Information
13.10.2 Depomed Prescription Pain Medications Product Offered
13.10.3 Depomed Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Depomed Main Business Overview
13.10.5 Depomed Latest Developments
13.11 Teva
13.11.1 Teva Company Information
13.11.2 Teva Prescription Pain Medications Product Offered
13.11.3 Teva Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Teva Main Business Overview
13.11.5 Teva Latest Developments
13.12 J&J
13.12.1 J&J Company Information
13.12.2 J&J Prescription Pain Medications Product Offered
13.12.3 J&J Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 J&J Main Business Overview
13.12.5 J&J Latest Developments
13.13 Allergan
13.13.1 Allergan Company Information
13.13.2 Allergan Prescription Pain Medications Product Offered
13.13.3 Allergan Prescription Pain Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Allergan Main Business Overview
13.13.5 Allergan Latest Developments
14 Research Findings and Conclusion
Table 1. Prescription Pain Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Prescription Pain Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Prescription NSAIDs
Table 4. Major Players of Opioids
Table 5. Major Players of Anti-epileptic Medicines
Table 6. Major Players of Antidepressants
Table 7. Major Players of Others
Table 8. Global Prescription Pain Medications Sales by Type (2017-2022) & (K Units)
Table 9. Global Prescription Pain Medications Sales Market Share by Type (2017-2022)
Table 10. Global Prescription Pain Medications Revenue by Type (2017-2022) & ($ million)
Table 11. Global Prescription Pain Medications Revenue Market Share by Type (2017-2022)
Table 12. Global Prescription Pain Medications Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Prescription Pain Medications Sales by Application (2017-2022) & (K Units)
Table 14. Global Prescription Pain Medications Sales Market Share by Application (2017-2022)
Table 15. Global Prescription Pain Medications Revenue by Application (2017-2022)
Table 16. Global Prescription Pain Medications Revenue Market Share by Application (2017-2022)
Table 17. Global Prescription Pain Medications Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Prescription Pain Medications Sales by Company (2020-2022) & (K Units)
Table 19. Global Prescription Pain Medications Sales Market Share by Company (2020-2022)
Table 20. Global Prescription Pain Medications Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Prescription Pain Medications Revenue Market Share by Company (2020-2022)
Table 22. Global Prescription Pain Medications Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Prescription Pain Medications Producing Area Distribution and Sales Area
Table 24. Players Prescription Pain Medications Products Offered
Table 25. Prescription Pain Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Prescription Pain Medications Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Prescription Pain Medications Sales Market Share Geographic Region (2017-2022)
Table 30. Global Prescription Pain Medications Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Prescription Pain Medications Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Prescription Pain Medications Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Prescription Pain Medications Sales Market Share by Country/Region (2017-2022)
Table 34. Global Prescription Pain Medications Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Prescription Pain Medications Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Prescription Pain Medications Sales by Country (2017-2022) & (K Units)
Table 37. Americas Prescription Pain Medications Sales Market Share by Country (2017-2022)
Table 38. Americas Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Prescription Pain Medications Revenue Market Share by Country (2017-2022)
Table 40. Americas Prescription Pain Medications Sales by Type (2017-2022) & (K Units)
Table 41. Americas Prescription Pain Medications Sales Market Share by Type (2017-2022)
Table 42. Americas Prescription Pain Medications Sales by Application (2017-2022) & (K Units)
Table 43. Americas Prescription Pain Medications Sales Market Share by Application (2017-2022)
Table 44. APAC Prescription Pain Medications Sales by Region (2017-2022) & (K Units)
Table 45. APAC Prescription Pain Medications Sales Market Share by Region (2017-2022)
Table 46. APAC Prescription Pain Medications Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Prescription Pain Medications Revenue Market Share by Region (2017-2022)
Table 48. APAC Prescription Pain Medications Sales by Type (2017-2022) & (K Units)
Table 49. APAC Prescription Pain Medications Sales Market Share by Type (2017-2022)
Table 50. APAC Prescription Pain Medications Sales by Application (2017-2022) & (K Units)
Table 51. APAC Prescription Pain Medications Sales Market Share by Application (2017-2022)
Table 52. Europe Prescription Pain Medications Sales by Country (2017-2022) & (K Units)
Table 53. Europe Prescription Pain Medications Sales Market Share by Country (2017-2022)
Table 54. Europe Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Prescription Pain Medications Revenue Market Share by Country (2017-2022)
Table 56. Europe Prescription Pain Medications Sales by Type (2017-2022) & (K Units)
Table 57. Europe Prescription Pain Medications Sales Market Share by Type (2017-2022)
Table 58. Europe Prescription Pain Medications Sales by Application (2017-2022) & (K Units)
Table 59. Europe Prescription Pain Medications Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Prescription Pain Medications Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Prescription Pain Medications Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Prescription Pain Medications Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Prescription Pain Medications Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Prescription Pain Medications Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Prescription Pain Medications Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Prescription Pain Medications Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Prescription Pain Medications
Table 69. Key Market Challenges & Risks of Prescription Pain Medications
Table 70. Key Industry Trends of Prescription Pain Medications
Table 71. Prescription Pain Medications Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Prescription Pain Medications Distributors List
Table 74. Prescription Pain Medications Customer List
Table 75. Global Prescription Pain Medications Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Prescription Pain Medications Sales Market Forecast by Region
Table 77. Global Prescription Pain Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Prescription Pain Medications Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Prescription Pain Medications Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Prescription Pain Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Prescription Pain Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Prescription Pain Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Prescription Pain Medications Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Prescription Pain Medications Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Prescription Pain Medications Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Prescription Pain Medications Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Prescription Pain Medications Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Prescription Pain Medications Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Prescription Pain Medications Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Prescription Pain Medications Revenue Market Share Forecast by Application (2023-2028)
Table 95. Pfizer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Prescription Pain Medications Product Offered
Table 97. Pfizer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. GSK Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 101. GSK Prescription Pain Medications Product Offered
Table 102. GSK Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. GSK Main Business
Table 104. GSK Latest Developments
Table 105. Grunenthal Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 106. Grunenthal Prescription Pain Medications Product Offered
Table 107. Grunenthal Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Grunenthal Main Business
Table 109. Grunenthal Latest Developments
Table 110. Bayer Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 111. Bayer Prescription Pain Medications Product Offered
Table 112. Bayer Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. Sanofi Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi Prescription Pain Medications Product Offered
Table 117. Sanofi Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Sanofi Main Business
Table 119. Sanofi Latest Developments
Table 120. Eli Lilly Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 121. Eli Lilly Prescription Pain Medications Product Offered
Table 122. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Eli Lilly Main Business
Table 124. Eli Lilly Latest Developments
Table 125. AstraZeneca Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 126. AstraZeneca Prescription Pain Medications Product Offered
Table 127. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Latest Developments
Table 130. Endo Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 131. Endo Prescription Pain Medications Product Offered
Table 132. Endo Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Endo Main Business
Table 134. Endo Latest Developments
Table 135. Merck Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 136. Merck Prescription Pain Medications Product Offered
Table 137. Merck Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Merck Main Business
Table 139. Merck Latest Developments
Table 140. Depomed Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 141. Depomed Prescription Pain Medications Product Offered
Table 142. Depomed Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Depomed Main Business
Table 144. Depomed Latest Developments
Table 145. Teva Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 146. Teva Prescription Pain Medications Product Offered
Table 147. Teva Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Teva Main Business
Table 149. Teva Latest Developments
Table 150. J&J Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 151. J&J Prescription Pain Medications Product Offered
Table 152. J&J Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. J&J Main Business
Table 154. J&J Latest Developments
Table 155. Allergan Basic Information, Prescription Pain Medications Manufacturing Base, Sales Area and Its Competitors
Table 156. Allergan Prescription Pain Medications Product Offered
Table 157. Allergan Prescription Pain Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Allergan Main Business
Table 159. Allergan Latest Developments
List of Figures
Figure 1. Picture of Prescription Pain Medications
Figure 2. Prescription Pain Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Pain Medications Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Prescription Pain Medications Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Prescription Pain Medications Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Prescription NSAIDs
Figure 10. Product Picture of Opioids
Figure 11. Product Picture of Anti-epileptic Medicines
Figure 12. Product Picture of Antidepressants
Figure 13. Product Picture of Others
Figure 14. Global Prescription Pain Medications Sales Market Share by Type in 2021
Figure 15. Global Prescription Pain Medications Revenue Market Share by Type (2017-2022)
Figure 16. Prescription Pain Medications Consumed in Hospitals
Figure 17. Global Prescription Pain Medications Market: Hospitals (2017-2022) & (K Units)
Figure 18. Prescription Pain Medications Consumed in Clinics
Figure 19. Global Prescription Pain Medications Market: Clinics (2017-2022) & (K Units)
Figure 20. Prescription Pain Medications Consumed in Drugstores
Figure 21. Global Prescription Pain Medications Market: Drugstores (2017-2022) & (K Units)
Figure 22. Prescription Pain Medications Consumed in Others
Figure 23. Global Prescription Pain Medications Market: Others (2017-2022) & (K Units)
Figure 24. Global Prescription Pain Medications Sales Market Share by Application (2017-2022)
Figure 25. Global Prescription Pain Medications Revenue Market Share by Application in 2021
Figure 26. Prescription Pain Medications Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Prescription Pain Medications Revenue Market Share by Company in 2021
Figure 28. Global Prescription Pain Medications Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Prescription Pain Medications Revenue Market Share by Geographic Region in 2021
Figure 30. Global Prescription Pain Medications Sales Market Share by Region (2017-2022)
Figure 31. Global Prescription Pain Medications Revenue Market Share by Country/Region in 2021
Figure 32. Americas Prescription Pain Medications Sales 2017-2022 (K Units)
Figure 33. Americas Prescription Pain Medications Revenue 2017-2022 ($ Millions)
Figure 34. APAC Prescription Pain Medications Sales 2017-2022 (K Units)
Figure 35. APAC Prescription Pain Medications Revenue 2017-2022 ($ Millions)
Figure 36. Europe Prescription Pain Medications Sales 2017-2022 (K Units)
Figure 37. Europe Prescription Pain Medications Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Prescription Pain Medications Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Prescription Pain Medications Revenue 2017-2022 ($ Millions)
Figure 40. Americas Prescription Pain Medications Sales Market Share by Country in 2021
Figure 41. Americas Prescription Pain Medications Revenue Market Share by Country in 2021
Figure 42. United States Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Prescription Pain Medications Sales Market Share by Region in 2021
Figure 47. APAC Prescription Pain Medications Revenue Market Share by Regions in 2021
Figure 48. China Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Prescription Pain Medications Sales Market Share by Country in 2021
Figure 55. Europe Prescription Pain Medications Revenue Market Share by Country in 2021
Figure 56. Germany Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Prescription Pain Medications Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Prescription Pain Medications Revenue Market Share by Country in 2021
Figure 63. Egypt Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Prescription Pain Medications Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Prescription Pain Medications in 2021
Figure 69. Manufacturing Process Analysis of Prescription Pain Medications
Figure 70. Industry Chain Structure of Prescription Pain Medications
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...